We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > observations

News List

US FDA issues six observations to Natco Pharma’s API facility near Hyderabad expresspharma
August 13, 2019
Natco Pharma announced that the US health regulator has made six observations after the completion of inspection of active pharmaceutical ingredient (API) facility in Mekaguda Village, near Hyderabad.
US FDA concludes inspection of Lupin’s facility without any observations expressbpd
August 01, 2017
The company successful completes PAI and GMP inspection of its Pithampur manufacturing facility – Unit 1
Aurobindo Pharma gets six observations from US FDA for Hyderabad unit financialexpress
April 21, 2017
US FDA had conducted an inspection at the company’s Unit III, a formulations manufacturing facility at Bachupally, Hyderabad